Abstract: Objective To investigate the values of combined detection of GPC3 and AFP in diagnosis of
primary liver cancer (PLC). Methods Total of 107 patients with PLC, 49 patients with common liver disease,
45 patients with other cancer and 45 cases of healthy controls were selected. AFP was detected by Abbott
ARCHITECT i2000SR and GPC3 was detected by ELISA methods. Results GPC3 levels in PLC group was
significantly higher than that of normal liver group, the other tumor group and healthy group, the differences
were statistically significant (P = 0.00). The sensitivity of GPC3, AFP and combined detection in diagnosis of
PLC were 58.88%, 62.62%, 91.59% and the AUC were 0.71, 0.73, 0.92, respectively. Conclusion Combined
detection of GPC3 and AFP can improve the sensitivity and diagnostic value of PLC diagnosis.
|